'It’s Hard To Call This Healthy'

Invariably, there will be plenty of BTFD’ers claiming victory on Tuesday assuming the rally holds into the close.

Of course if you’re just now getting long on dips, your victories will almost assuredly prove to be of the pyrrhic variety.

Even if the rally hobbles along, buying at elevated valuations all but guarantees that your returns will be lackluster – that’s almost tautological.

Whatever. It’s your money.

One thing worth keeping in mind (and we’ve been talking about it a lot lately) is market breadth or, more appropriately, a lack thereof. If you’ve missed our recent posts on this, you can find a few of them here:

As you look out across screens that are largely green on Tuesday, here’s some new commentary on the breadth issue from Bloomberg’s Heather Burke…

Via Bloomberg

It’s hard to call today’s rally – and recent rallies overall – healthy when it’s not widely distributed across sectors and stocks. Some of it may be due to the “anemic” and “hobbled” volume.

But there’s a distinctive lack of breadth that bolsters the few (often tech and FAANG) at the expense of many. Could it be because the market is more determined by big moves from individual companies than the macro?

S&P 500 breadth, as measured by the percentage of stocks above their 50-DMA, is at lows not seen since Dec. 2016. For the Russell 3000, it’s a similar story. Year-to-date, the S&P 500 info tech sector is up almost 23%. The next highest sector, health care, is up 15%.

S&PInfoTechVHC

 

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.